Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2004-01-01 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GRADIGNAN (33170), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LAURENZANE : revenue, balance sheet and financial ratios
PHARMACIE LAURENZANE is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GRADIGNAN (33170),
this company of category PME
shows in 2024 a net income positive of 46 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LAURENZANE (SIREN 452267149)
Indicator
2024
2023
Revenue
N/C
N/C
Net income
46 414 €
-106 704 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE LAURENZANE generates positive net income of 46 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
46 414 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 34%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
34.229%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
67.757%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
Debt ratio
1.188
34.229
Financial autonomy
80.569
67.757
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
34.232024
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good+11 pts over 2 years
In 2024, the debt ratio of PHARMACIE LAURENZANE (34.23) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
67.76%2024
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good
In 2024, the financial autonomy of PHARMACIE LAURENZANE (67.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 237.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
Liquidity ratio
144.586
237.64
Interest coverage
None
None
Sector positioning
Liquidity ratio
237.642024
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good+38 pts over 2 years
In 2024, the liquidity ratio of PHARMACIE LAURENZANE (237.64) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE LAURENZANE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE LAURENZANE is estimated at
647 973 €
(range 451 238€ - 969 405€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
451k€647k€969k€
647 973 €Range: 451 238€ - 969 405€
NAF 5 année 2024
Valuation method used
Net Income Multiple
46 414 €
×
14.0x
=647 974 €
Range: 451 239€ - 969 406€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LAURENZANE with other companies in the same sector:
Frequently asked questions about PHARMACIE LAURENZANE
What is the revenue of PHARMACIE LAURENZANE ?
The revenue of PHARMACIE LAURENZANE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LAURENZANE profitable?
Yes, PHARMACIE LAURENZANE generated a net profit of 46 k€ in 2024.
Where is the headquarters of PHARMACIE LAURENZANE ?
The headquarters of PHARMACIE LAURENZANE is located in GRADIGNAN (33170), in the department Gironde.
Where to find the tax return of PHARMACIE LAURENZANE ?
The tax return of PHARMACIE LAURENZANE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LAURENZANE operate?
PHARMACIE LAURENZANE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart